VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,343,758 | -31.4% | 633,848 | 0.0% | 0.01% | -27.3% |
Q2 2023 | $1,958,590 | -42.6% | 633,848 | 0.0% | 0.01% | -42.1% |
Q1 2023 | $3,410,102 | -65.0% | 633,848 | -56.8% | 0.02% | -67.8% |
Q4 2022 | $9,748,401 | +67.1% | 1,465,925 | 0.0% | 0.06% | +55.3% |
Q3 2022 | $5,834,000 | +3.1% | 1,465,925 | +28.7% | 0.04% | +18.8% |
Q2 2022 | $5,660,000 | – | 1,138,768 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |